- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-41/15: Order of the General Court of 2 December 2015 — Novartis v OHIM– Mabxience (HERTIXAN) (Community trade mark — Opposition proceedings — Withdrawal of application for registration — No need to adjudicate)
ECLI:EU:UNKNOWN:62015TB0041
62015TB0041
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C 38/58
(Case T-41/15)(<span class="super">1</span>)
((Community trade mark - Opposition proceedings - Withdrawal of application for registration - No need to adjudicate))
(2016/C 038/77)
Language of the case: Spanish
Parties
Applicant: Novartis AG (Basel, Switzerland) (represented by: M. Douglas, lawyer)
Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: S. Palmero Cabezas, Agent)
Other party to the proceedings before the Board of Appeal of OHIM: Mabxience SA (Montevideo, Uruguay)
Re:
Action brought against the decision of the First Board of Appeal of OHIM of 31 October 2014 (Case R 2550/2013-1) relating to opposition proceedings between Novartis AG and Mabxience SA.
Operative part of the order
1.There is no need to adjudicate on the action.
2.Novartis AG is ordered to pay the costs.
(<span class="super">1</span>) OJ C 107, 30.3.2015.